Core Viewpoint - Pulsenmore Ltd. is set to release its financial results for the full year 2025 on March 30, 2026, and will host a conference call to discuss these results along with business highlights and recent progress [1][2]. Company Overview - Pulsenmore Ltd. focuses on revolutionizing maternal health through home-use ultrasound technology, enabling remote connections between mothers and healthcare providers [3]. - The company aims to enhance prenatal care by making it more patient-centric, thereby expanding access and improving continuity of care [3]. Conference Call Details - The conference call is scheduled for March 30, 2026, at 8:30 a.m. Eastern Time, with a webcast available for participants [2]. - Key executives, including the Chairman, CEO, CFO, and VP of Marketing, will lead the call to review financial results and strategic initiatives [2]. Recent Developments - Pulsenmore has been building momentum in the U.S. market following its Nasdaq listing and FDA De Novo authorization, indicating a focus on expanding clinician adoption and market presence [3].